1	Suspendería	suspender	VMIC3S0	-	-	0-11	579_ANS_clinical_caseMIR	SENT1	-	-
2	antidiabéticos	antidiabético	NCMP000	-	-	12-26	579_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
3	orales	oral	AQ0CP0	C0442027	calificador	27-33	579_ANS_clinical_caseMIR	SENT1	-	-
4	y	y	CC	C1706368	calificador	34-35	579_ANS_clinical_caseMIR	SENT1	-	-
5	pautaría	pautar	VMIC3S0	-	-	36-44	579_ANS_clinical_caseMIR	SENT1	-	-
6	insulinoterapia	insulinoterapia	NCFS000	-	-	45-60	579_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
7	.	.	Fp	-	-	60-61	579_ANS_clinical_caseMIR	SENT1	-	-

1	Continuaría	continuar	VMIC3S0	-	-	0-11	579_ANS_clinical_caseMIR	SENT2	-	-
2	con	con	SPS00	C0332287	atributo	12-15	579_ANS_clinical_caseMIR	SENT2	-	-
3	metformina	metformina	NC00SC0	C0025598	producto#sustancia	16-26	579_ANS_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
4	a	a	SPS00	-	-	27-28	579_ANS_clinical_caseMIR	SENT2	-	-
5	dosis	dosis	NCFN000	-	-	29-34	579_ANS_clinical_caseMIR	SENT2	-	-
6	altas	alto	AQ0FP0	C0205250	calificador	35-40	579_ANS_clinical_caseMIR	SENT2	-	-
7	y	y	CC	C1706368	calificador	41-42	579_ANS_clinical_caseMIR	SENT2	-	-
8	añadiría	añadir	VMIC3S0	-	-	43-51	579_ANS_clinical_caseMIR	SENT2	-	-
9	insulina	insulina	NCFS000	C0021641	sustancia	52-60	579_ANS_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
10	de	de	SPS00	C0332285	atributo	61-63	579_ANS_clinical_caseMIR	SENT2	-	-
11	acción	acción	NCFS000	C0441472#C3266814	calificador#atributo	64-70	579_ANS_clinical_caseMIR	SENT2	-	-
12	lenta	lento	AQ0FS0	C0439834	calificador	71-76	579_ANS_clinical_caseMIR	SENT2	-	-
13	.	.	Fp	-	-	76-77	579_ANS_clinical_caseMIR	SENT2	-	-

1	Mantendría	mantener	VMIC3S0	-	-	0-10	579_ANS_clinical_caseMIR	SENT3	-	-
2	vildagliptina	vildagliptina	NC00SC0	C1570906	producto#sustancia	11-24	579_ANS_clinical_caseMIR	SENT3	B-Grp_Medicamento	-
3	,	,	Fc	-	-	24-25	579_ANS_clinical_caseMIR	SENT3	-	-
4	pero	pero	CC	-	-	26-30	579_ANS_clinical_caseMIR	SENT3	-	-
5	suspendería	suspender	VMIC3S0	-	-	31-42	579_ANS_clinical_caseMIR	SENT3	-	-
6	metformina	metformina	NC00SC0	C0025598	producto#sustancia	43-53	579_ANS_clinical_caseMIR	SENT3	B-Grp_Medicamento	-
7	.	.	Fp	-	-	53-54	579_ANS_clinical_caseMIR	SENT3	-	-

1	Continuaría	continuar	VMIC3S0	-	-	0-11	579_ANS_clinical_caseMIR	SENT4	-	-
2	con	con	SPS00	C0332287	atributo	12-15	579_ANS_clinical_caseMIR	SENT4	-	-
3	igual	igual	AQ0CS0	C0205163	calificador	16-21	579_ANS_clinical_caseMIR	SENT4	-	-
4	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	22-33	579_ANS_clinical_caseMIR	SENT4	-	-
5	,	,	Fc	-	-	33-34	579_ANS_clinical_caseMIR	SENT4	-	-
6	ya	ya	RG	-	-	35-37	579_ANS_clinical_caseMIR	SENT4	-	-
7	que	que	PR0CN000	-	-	38-41	579_ANS_clinical_caseMIR	SENT4	-	-
8	el	el	DA0MS0	-	-	42-44	579_ANS_clinical_caseMIR	SENT4	-	-
9	paciente	paciente	NCCS000	C0030705	persona	45-53	579_ANS_clinical_caseMIR	SENT4	-	-
10	estaba	estar	VAII3S0	-	-	54-60	579_ANS_clinical_caseMIR	SENT4	-	-
11	bien	bien	RG	C0205170	calificador	61-65	579_ANS_clinical_caseMIR	SENT4	-	-
12	controlado	controlar	VMP00SM	-	-	66-76	579_ANS_clinical_caseMIR	SENT4	-	-
13	.	.	Fp	-	-	76-77	579_ANS_clinical_caseMIR	SENT4	-	-

